Product Information

TOPIRAMATE ER 50 MG SPRINKL CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $3.3778 per EA under NDC 00832107230. Its NADAC has been published 536 times since Jul 22, 2015.

FDA first approved this application on Mar 11, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 50 MG SPRINKL CAP

Topiramate
$3.3778per EA

Strength

50 mg/1

NDC

00832107230

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA205122

FDA Approved

3/11/2014

TE Code

AB2

On Market Since

7/7/2014

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 50 MG SPRINKL CAP has been published 536 times since Jul 22, 2015, and over the history we have for it it has declined 31.9%. The table below summarizes its recorded NADAC range and movement.

Current price$3.3778 per EA
All-time high$8.9632 (Jul 13, 2022)
All-time low$3.3778 (Aug 19, 2026)
52-week high$5.5824
52-week low$3.3778
Median price$6.6409
Average price$6.5203
Largest weekly change-26.0% (Jul 17, 2024)
Weeks tracked536
Tracking sinceJul 22, 2015

Price History

1W

-7.9%

1M

-7.9%

3M

-5.3%

6M

-33.0%

1Y

-31.7%

3Y

-48.8%

5Y

-61.2%

All

-31.9%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 50 MG SPRINKL CAP?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 50 MG SPRINKL CAP, manufactured by Upsher-Smith Laboratories LLC, is $3.3778 per EA (NDC 00832107230), effective Aug 19, 2026.

How has the price of TOPIRAMATE ER 50 MG SPRINKL CAP changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 50 MG SPRINKL CAP has declined 31.9%. It has been tracked across 536 weekly CMS publications since Jul 22, 2015.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 50 MG SPRINKL CAP?

Since Jul 22, 2015, the NADAC for TOPIRAMATE ER 50 MG SPRINKL CAP has ranged from a low of $3.3778 (Aug 19, 2026) to a high of $8.9632 (Jul 13, 2022), with a median of $6.6409 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 50 MG SPRINKL CAP?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE ER 50 MG SPRINKL CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE ER 50 MG SPRINKL CAP?

TOPIRAMATE ER 50 MG SPRINKL CAP (NDC 00832107230) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.